CRIPAK Blocking Peptide (Center)
€363.00
In stock
SKU
AC-BP21790c
Background:
Negative regulator of PAK1. It has been suggested that the lost of CRIPAK in breast tumors might contribute to hormonal independence.
Other Names:
Cysteine-rich PAK1 inhibitor, CRIPak, CRIPAK
Target/Specificity:
The synthetic peptide sequence is selected from aa 154-165 of HUMAN CRIPAK
Primary Accession: Q8N1N5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Negative regulator of PAK1. It has been suggested that the lost of CRIPAK in breast tumors might contribute to hormonal independence.
Other Names:
Cysteine-rich PAK1 inhibitor, CRIPak, CRIPAK
Target/Specificity:
The synthetic peptide sequence is selected from aa 154-165 of HUMAN CRIPAK
Primary Accession: Q8N1N5
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review